Literature DB >> 20708417

The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes.

Christina Voulgari1, Michael Psallas, Alexander Kokkinos, Vasiliki Argiana, Nicholas Katsilambros, Nicholas Tentolouris.   

Abstract

BACKGROUND: Cardiac autonomic neuropathy (CAN) is a common diabetes complication associated with poor prognosis. This cross-sectional study aimed to examine for associations between CAN and metabolic and other parameters in patients with either type 1 (T1DM) or type 2 (T2DM) diabetes. PATIENTS AND METHODS: A total of 600 patients (T1DM, n=200; T2DM, n=400) were recruited. Participants with overt nephropathy, macrovascular complications, and treated hypertension were excluded. CAN was diagnosed when two of the four classical autonomic function tests were abnormal.
RESULTS: CAN was diagnosed in 42.0% and in 44.3% of the participants with T1DM and T2DM, respectively. Multivariate logistic regression analysis demonstrated that, in T1DM, the odds [OR (95% confidence intervals)] of CAN increased with higher waist circumference [1.36 (1.01-2.02)], systolic blood pressure [1.16 (1.03-1.31)], hypertension [1.19 (1.03-2.67)], smoking [1.10 (1.12-1.40], fasting glucose [1.01 (1.00-1.01)], HbA(1c) [1.69 (1.07-2.76)], pubertal diabetes onset [1.08 (1.03-1.24)], LDL cholesterol [1.01(1.00-1.02)], triglycerides [1.58 (1.24-1.48)], retinopathy [1.13 (1.04-1.41)], peripheral neuropathy [2.53 (1.07-2.99)], glomerular filtration rate [0.93 (0.87-0.99)], and microalbuminuria [1.24 (1.12-1.36)]. The same analysis in T2DM demonstrated that the odds of CAN increased with higher waist circumference [1.08 (1.00-1.39)], systolic blood pressure [1.06 (1.02-1.12)], hypertension [1.50 (1.24-2.03)], smoking [1.22 (1.14-1.49)], diabetes duration [1.20 (1.09-1.34)], fasting glucose [1.21 (1.12-1.31)], HbA(1c) [1.25 (1.08-1.45)], LDL cholesterol [1.35 (1.04-1.75)], triglycerides [1.30 (1.00-1.68)], retinopathy [1.24 (1.16-1.35)], peripheral neuropathy [1.79 (1.07-2.01)], glomerular filtration rate [0.96 (0.95-0.97)], and microalbuminuria [1.20 (1.14-1.36)].
CONCLUSIONS: CAN is common in diabetes and is associated with modifiable factors including central fat distribution, hypertension, dyslipidemia, worse diabetes control, and smoking, and with the other microvascular complications of diabetes. Our findings emphasize the need for a multifactorial intervention for the prevention of CAN.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20708417     DOI: 10.1016/j.jdiacomp.2010.06.001

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  24 in total

Review 1.  Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes.

Authors:  Martin Röhling; Alexander Strom; Gidon J Bönhof; Michael Roden; Dan Ziegler
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

2.  Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study.

Authors:  M Charles; J Fleischer; D R Witte; N Ejskjaer; K Borch-Johnsen; T Lauritzen; A Sandbaek
Journal:  Diabetologia       Date:  2012-10-12       Impact factor: 10.122

3.  Predictors of physical inactivity in men and women with type 2 diabetes from the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.

Authors:  Margaret M McCarthy; Janice Davey; Frans J Th Wackers; Deborah A Chyun
Journal:  Diabetes Educ       Date:  2014-06-18       Impact factor: 2.140

4.  Autonomic neuropathy in HIV is unrecognized and associated with medical morbidity.

Authors:  Jessica Robinson-Papp; Sandeep K Sharma
Journal:  AIDS Patient Care STDS       Date:  2013-09-13       Impact factor: 5.078

Review 5.  The ECG vertigo in diabetes and cardiac autonomic neuropathy.

Authors:  Christina Voulgari; Nicholas Tentolouris; Christodoulos Stefanadis
Journal:  Exp Diabetes Res       Date:  2011-05-29

6.  Letter: diabetic polyneuropathy and cardiovascular complications in type 2 diabetic patients (diabetes metab j 2011;35:390-6).

Authors:  Sun-Hye Ko; Seung-Hyun Ko
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

Review 7.  Identifying Common Genetic Risk Factors of Diabetic Neuropathies.

Authors:  Ini-Isabée Witzel; Herbert F Jelinek; Kinda Khalaf; Sungmun Lee; Ahsan H Khandoker; Habiba Alsafar
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-28       Impact factor: 5.555

8.  Cardiovascular autonomic neuropathy in context of other complications of type 2 diabetes mellitus.

Authors:  Anca Moţăţăianu; Rodica Bălaşa; Septimiu Voidăzan; Zoltán Bajkó
Journal:  Biomed Res Int       Date:  2013-12-18       Impact factor: 3.411

Review 9.  Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus.

Authors:  Yubi Lin; Hairui Li; Xianwu Lan; Xianghui Chen; Aidong Zhang; Zicheng Li
Journal:  ScientificWorldJournal       Date:  2013-03-14

10.  Influence of visceral adiposity on cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus.

Authors:  Eun-Hee Jang; Na-Young Kim; Yong-Moon Park; Mee-Kyoung Kim; Ki Hyun Baek; Ki-Ho Song; Kwang Woo Lee; Hyuk-Sang Kwon
Journal:  Diabetes Metab J       Date:  2012-08-20       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.